The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,840.00
Bid: 1,834.00
Ask: 1,844.00
Change: -10.00 (-0.54%)
Spread: 10.00 (0.545%)
Open: 1,848.00
High: 1,852.00
Low: 1,836.00
Prev. Close: 1,850.00
RCP Live PriceLast checked at -
RIT Capital Partners is an Investment Trust

To invest in a widely diversified, international portfolio across a range of asset classes, both quoted and unquoted; to allocate part of the portfolio to exceptional managers in order to ensure access to the best external talent available.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

26 May 2020 17:15

RNS Number : 9838N
RIT Capital Partners PLC
26 May 2020
 

26 May 2020

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667) 

RESULT OF ANNUAL GENERAL MEETING - (ALL RESOLUTIONS PASSED)

AND DIRECTORATE CHANGES

 

The Annual General Meeting of RIT Capital Partners plc ('Company') was held on Tuesday 26 May 2020.

All resolutions as set out in the Notice of Meeting dated 20 April 2020 were passed and prints of the items of special business passed will shortly be available for inspection on the National Storage Mechanism.

 

The proxy votes cast on each resolution were as follow:

RESOLUTION

 FOR/

DISCRETIONARY

 AGAINST

VOTES

WITHHELD

ORDINARY BUSINESS:

1.

Approval of the Directors' Report and Accounts for the year ended 31 December 2019

73,390,547

30,116

3,683,630

2.

Approval of the Directors' Remuneration Report for the year ended 31 December 2019

54,665,997

8,175,770

17,029,086

3.

Approval of the Directors' Remuneration Policy

75,438,607

62,857

4,367,470

4.

Re-election of Sir James Leigh-Pemberton as a Director

72,759,384

620,902

3,720,687

5.

Re-election of Philippe Costeletos as a Director

73,369,407

13,545

3,720,342

6.

Re-election of Maggie Fanari as a Director

73,396,486

18,611

3,688,197

7.

Re-election of André Perold as a Director

73,374,907

6,775

3,721,612

8.

Re-election of Mike Power as a Director

73,378,128

2,832

3,722,334

9.

Re-election of Hannah Rothschild as a Director

73,406,594

11,650

3,685,050

10.

Re-election of Jeremy Sillem as a Director

50,570,344

22,812,151

3,720,798

11.

Re-election of Amy Stirling as a Director

73,411,761

3,336

3,688,197

12.

Election of Maxim Parr as a Director

73,365,811

8,504

3,728,979

13.

Election of Jonathan Sorrell as a Director

73,361,491

15,663

3,726,140

14.

Re-appointment of Ernst & Young LLP as auditors

73,355,614

44,946

3,702,734

15.

To authorise the Directors to fix the remuneration of the auditors

73,404,247

10,172

3,688,875

SPECIAL BUSINESS:

16.

To renew the power to allot equity securities

73,289,222

121,969

3,692,103

17.

To authorise the Directors to allot equity securities for cash

73,406,494

6,433,756

31,129

18.

To renew the authority to repurchase up to 14.99 per cent. of the Company's issued share capital

70,119,541

35,992

3,689,114

19.

To change the notice period for general meetings other than annual general meetings to 14 days

69,375,318

785,171

3,684,158

 

 

Resolutions 1 to 16 were passed as ordinary resolutions and resolutions 17 to 19 were passed as special resolutions. The Board notes that Resolution 10 was passed with more than 20% of votes against. Therefore, the Company will continue to consult relevant shareholders and will respond in due course.

 

Election of Directors

Following the passing of all resolutions by shareholders at its Annual General Meeting, the Company announces the following elections to the Board with immediate effect:

 

Maxim Parr

Maxim Parr started his career at Jardine Matheson and has over 15 years' experience working in cross-border investment between Asia and Europe. Maxim lived in Beijing for well over a decade where, as Founder and CEO of Atlas Capital Group, he worked alongside FTSE 100 and European corporates on their China investment strategy in startups, growth capital and buyouts. Working between Paris and Asia, Maxim is co-founder and CEO of nr2, a cross border technology investment platform.

There are no other details that require to be disclosed in respect of his appointment pursuant to Rule 9.6.13 of the UK Listing Rules.

 

Jonathan Sorrell

Jonathan Sorrell is President of Capstone, a global asset manager, having previously been President of Man Group plc. As President of Man Group, Jonathan had responsibility for global sales and marketing, certain investment businesses (Man Global Private Markets and Man Financial Risk Management) and group strategy and M&A. Previously, Jonathan was Chief Financial Officer of Man Group, having joined from Goldman Sachs where he was a Managing Director.

There are no other details that require to be disclosed in respect of his appointment pursuant to Rule 9.6.13 of the UK Listing Rules.

 

Composition of Board Committees

Pursuant to Listing Rule 9.6.11R, the Company announces the following changes to the composition of its Board Committees with immediate effect:

Jonathan Sorrell has been appointed to the Audit and Risk Committee;

Maxim Parr has been appointed to the Conflicts Committee, and the Valuation Committee;

Philippe Costeletos has been appointed to the Nominations Committee;

Sir James Leigh-Pemberton has been appointed to the Remuneration Committee; and

Jeremy Sillem has stepped down from the Audit and Risk Committee.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGAFMFTMTMTBTM
Date   Source Headline
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection
16th Sep 20197:00 amRNSNet Asset Value(s)
14th Aug 20197:00 amRNSNet Asset Value(s)
5th Aug 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNet Asset Value(s)
3rd Jul 20192:42 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
18th Jun 20195:04 pmRNSDirector/PDMR Shareholding
17th Jun 20194:20 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSNet Asset Value(s)
15th May 20197:00 amRNSNet Asset Value(s)
12th Apr 20197:00 amRNSNet Asset Value(s)
3rd Apr 20193:59 pmRNSQUARTERLY DISCLOSURE - Listing Rule 15.6.8
22nd Mar 20194:01 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSNet Asset Value(s)
5th Mar 20197:00 amRNSAnnual Financial Report
18th Feb 20197:00 amRNSNet Asset Value(s)
5th Feb 20197:00 amRNSNet Asset Value(s)
8th Jan 201910:02 amRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Dec 20187:00 amRNSNet Asset Value(s)
30th Nov 201810:53 amRNSComposition of Board Committee
14th Nov 20187:00 amRNSNet Asset Value(s)
29th Oct 20184:59 pmRNSComposition of Board Committee
16th Oct 201811:11 amRNSDirector Declaration
12th Oct 20187:00 amRNSNet Asset Value(s)
5th Oct 20185:03 pmRNSDirector/PDMR Shareholding
4th Oct 20185:46 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Sep 20187:00 amRNSNet Asset Value(s)
24th Aug 20183:15 pmRNSAppointment of Joint Broker
14th Aug 20187:00 amRNSNet Asset Value(s)
7th Aug 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNet Asset Value(s)
3rd Jul 20186:00 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Jun 20187:00 amRNSNet Asset Value(s)
15th May 20187:00 amRNSNet Asset Value(s)
26th Apr 201812:41 pmRNSDirectorate Change
26th Apr 201812:27 pmRNSResult of AGM
16th Apr 20187:25 amRNSNet Asset Value(s)
6th Apr 20185:54 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
28th Mar 20185:09 pmRNSDirector/PDMR Shareholding
26th Mar 201811:54 amRNSDirectorate Change
14th Mar 20187:00 amRNSNet Asset Value(s)
5th Mar 20186:00 pmRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSFinal Results and Dividend
14th Feb 20187:00 amRNSNet Asset Value(s)
5th Feb 201810:02 amRNSInitiation research from QuotedData

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.